BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20643615)

  • 21. Microdeletion at chromosome 4q21 defines a new emerging syndrome with marked growth restriction, mental retardation and absent or severely delayed speech.
    Bonnet C; Andrieux J; Béri-Dexheimer M; Leheup B; Boute O; Manouvrier S; Delobel B; Copin H; Receveur A; Mathieu M; Thiriez G; Le Caignec C; David A; de Blois MC; Malan V; Philippe A; Cormier-Daire V; Colleaux L; Flori E; Dollfus H; Pelletier V; Thauvin-Robinet C; Masurel-Paulet A; Faivre L; Tardieu M; Bahi-Buisson N; Callier P; Mugneret F; Edery P; Jonveaux P; Sanlaville D
    J Med Genet; 2010 Jun; 47(6):377-84. PubMed ID: 20522426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A de novo 15q13.2q13.3 deletion in a boy with an Angelman syndrome like phenotype.
    Barøy T; Misceo D; Braaten O; Helle JR; Fannemel M; Strømme P; Frengen E
    Eur J Med Genet; 2010; 53(4):221-4. PubMed ID: 20382277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 6q terminal deletion syndrome associated with a distinctive EEG and clinical pattern: a report of five cases.
    Elia M; Striano P; Fichera M; Gaggero R; Castiglia L; Galesi O; Malacarne M; Pierluigi M; Amato C; Musumeci SA; Romano C; Majore S; Grammatico P; Zara F; Striano S; Faravelli F
    Epilepsia; 2006 May; 47(5):830-8. PubMed ID: 16686647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epilepsy and the new cytogenetics.
    Mulley JC; Mefford HC
    Epilepsia; 2011 Mar; 52(3):423-32. PubMed ID: 21269290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiplex ligation-dependent probe amplification to detect subtelomeric rearrangements in routine diagnostics.
    Rooms L; Reyniers E; Wuyts W; Storm K; van Luijk R; Scheers S; Wauters J; van den Ende J; Biervliet M; Eyskens F; van Goethem G; Laridon A; Ceulemans B; Courtens W; Kooy RF
    Clin Genet; 2006 Jan; 69(1):58-64. PubMed ID: 16451137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absence seizures with intellectual disability as a phenotype of the 15q13.3 microdeletion syndrome.
    Muhle H; Mefford HC; Obermeier T; von Spiczak S; Eichler EE; Stephani U; Sander T; Helbig I
    Epilepsia; 2011 Dec; 52(12):e194-8. PubMed ID: 22050399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epilepsy in patients with angelman syndrome caused by deletion of the chromosome 15q11-13.
    Valente KD; Koiffmann CP; Fridman C; Varella M; Kok F; Andrade JQ; Grossmann RM; Marques-Dias MJ
    Arch Neurol; 2006 Jan; 63(1):122-8. PubMed ID: 16401744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular characterisation of patients with subtelomeric 22q abnormalities using chromosome specific array-based comparative genomic hybridisation.
    Koolen DA; Reardon W; Rosser EM; Lacombe D; Hurst JA; Law CJ; Bongers EM; van Ravenswaaij-Arts CM; Leisink MA; van Kessel AG; Veltman JA; de Vries BB
    Eur J Hum Genet; 2005 Sep; 13(9):1019-24. PubMed ID: 15986041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High rate of detection of subtelomeric aberration by using combined MLPA and subtelomeric FISH approach in patients with moderate to severe mental retardation.
    Lam AC; Lam ST; Lai KK; Tong TM; Chau TC
    Clin Biochem; 2006 Mar; 39(3):196-202. PubMed ID: 16497288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes.
    Bruno DL; Anderlid BM; Lindstrand A; van Ravenswaaij-Arts C; Ganesamoorthy D; Lundin J; Martin CL; Douglas J; Nowak C; Adam MP; Kooy RF; Van der Aa N; Reyniers E; Vandeweyer G; Stolte-Dijkstra I; Dijkhuizen T; Yeung A; Delatycki M; Borgström B; Thelin L; Cardoso C; van Bon B; Pfundt R; de Vries BB; Wallin A; Amor DJ; James PA; Slater HR; Schoumans J
    J Med Genet; 2010 May; 47(5):299-311. PubMed ID: 20452996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of cryptic subtelomeric chromosome abnormalities and identification of anonymous chromatin using a quantitative multiplex ligation-dependent probe amplification (MLPA) assay.
    Northrop EL; Ren H; Bruno DL; McGhie JD; Coffa J; Schouten J; Choo KH; Slater HR
    Hum Mutat; 2005 Nov; 26(5):477-86. PubMed ID: 16170807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of known and novel genomic rearrangements by array based comparative genomic hybridisation: deletion of ZNF533 and duplication of CHARGE syndrome genes.
    Monfort S; Roselló M; Orellana C; Oltra S; Blesa D; Kok K; Ferrer I; Cigudosa JC; Martínez F
    J Med Genet; 2008 Jul; 45(7):432-7. PubMed ID: 18413373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for subtelomeric rearrangements in 210 patients with unexplained mental retardation using multiplex ligation dependent probe amplification (MLPA).
    Koolen DA; Nillesen WM; Versteeg MH; Merkx GF; Knoers NV; Kets M; Vermeer S; van Ravenswaaij CM; de Kovel CG; Brunner HG; Smeets D; de Vries BB; Sistermans EA
    J Med Genet; 2004 Dec; 41(12):892-9. PubMed ID: 15591274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of chromosomal imbalances in children with idiopathic mental retardation by array based comparative genomic hybridisation (array-CGH).
    Schoumans J; Ruivenkamp C; Holmberg E; Kyllerman M; Anderlid BM; Nordenskjöld M
    J Med Genet; 2005 Sep; 42(9):699-705. PubMed ID: 16141005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterisation of dic(9;20)(p11-13;q11) in childhood B-cell precursor acute lymphoblastic leukaemia by tiling resolution array-based comparative genomic hybridisation reveals clustered breakpoints at 9p13.2 and 20q11.2.
    Schoumans J; Johansson B; Corcoran M; Kuchinskaya E; Golovleva I; Grandér D; Forestier E; Staaf J; Borg A; Gustafsson B; Blennow E; Nordgren A
    Br J Haematol; 2006 Nov; 135(4):492-9. PubMed ID: 16999846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular definition of chromosome arm 5q deletion end points and detection of hidden aberrations in patients with myelodysplastic syndromes and isolated del(5q) using oligonucleotide array CGH.
    Evers C; Beier M; Poelitz A; Hildebrandt B; Servan K; Drechsler M; Germing U; Royer HD; Royer-Pokora B
    Genes Chromosomes Cancer; 2007 Dec; 46(12):1119-28. PubMed ID: 17823930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization.
    Somiari SB; Shriver CD; He J; Parikh K; Jordan R; Hooke J; Hu H; Deyarmin B; Lubert S; Malicki L; Heckman C; Somiari RI
    Cancer Genet Cytogenet; 2004 Dec; 155(2):108-18. PubMed ID: 15571796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromosomal abnormality at 6p25.1-25.3 identifies a susceptibility locus for hypothalamic hamartoma associated with epilepsy.
    Kerrigan JF; Kruer MC; Corneveaux J; Panganiban CB; Itty A; Reiman D; Ng YT; Stephan DA; Craig DW
    Epilepsy Res; 2007 Jun; 75(1):70-3. PubMed ID: 17512701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA microarray analysis identifies candidate regions and genes in unexplained mental retardation.
    Engels H; Brockschmidt A; Hoischen A; Landwehr C; Bosse K; Walldorf C; Toedt G; Radlwimmer B; Propping P; Lichter P; Weber RG
    Neurology; 2007 Mar; 68(10):743-50. PubMed ID: 17339581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype.
    Kleefstra T; van Zelst-Stams WA; Nillesen WM; Cormier-Daire V; Houge G; Foulds N; van Dooren M; Willemsen MH; Pfundt R; Turner A; Wilson M; McGaughran J; Rauch A; Zenker M; Adam MP; Innes M; Davies C; López AG; Casalone R; Weber A; Brueton LA; Navarro AD; Bralo MP; Venselaar H; Stegmann SP; Yntema HG; van Bokhoven H; Brunner HG
    J Med Genet; 2009 Sep; 46(9):598-606. PubMed ID: 19264732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.